肠易激综合征治疗的新药物

被引：5

作者：

王化虹

机构：

[1] 北京大学第一医院消化科

来源：

中华消化杂志 | 2016年 / 36卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R574.4 [肠道功能紊乱];

学科分类号：

100201 [内科学];

摘要：

<正>

引用

共 17 条

[1]

抗抑郁药物治疗肠易激综合征的研究进展 [J].

姜亚 ;

汤玉蓉 ;

林琳 .

胃肠病学, 2015, 20 (08) :507-509

[2]

微生态制剂在肠易激综合征中的临床应用及评价 [J].

莫文辉 ;

郭传勇 .

世界临床药物, 2008, 29 (12) :722-726

[3]

Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis [J].

Ford, Alexander C. ;

Quigley, Eamonn M. M. ;

Lacy, Brian E. ;

Lembo, Anthony J. ;

Saito, Yuri A. ;

Schiller, Lawrence R. ;

Soffer, Edy E. ;

Spiegel, Brennan M. R. ;

Moayyedi, Paul .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (09) :1350-1365

[4]

Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome [J].

Raschi, Emanuel ;

De Ponti, Fabrizio .

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (02) :293-305

[5]

Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety [J].

Chey, William D. ;

Lembo, Anthony J. ;

Lavins, Bernard J. ;

Shiff, Steven J. ;

Kurtz, Caroline B. ;

Currie, Mark G. ;

MacDougall, James E. ;

Jia, Xinwei D. ;

Shao, James Z. ;

Fitch, Donald A. ;

Baird, Mollie J. ;

Schneier, Harvey A. ;

Johnston, Jeffrey M. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (11) :1702-1712

[6]

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation [J].

Rao, Satish ;

Lembo, Anthony J. ;

Shiff, Steven J. ;

Lavins, Bernard J. ;

Currie, Mark G. ;

Jia, Xinwei D. ;

Shi, Kelvin ;

MacDougall, James E. ;

Shao, James Z. ;

Eng, Paul ;

Fox, Susan M. ;

Schneier, Harvey A. ;

Kurtz, Caroline B. ;

Johnston, Jeffrey M. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (11) :1714-1724

[7]

Lubiprostone Targets Prostanoid Signaling and Promotes Ion Transporter Trafficking, Mucus Exocytosis, and Contractility [J].

Jakab, Robert L. ;

Collaco, Anne M. ;

Ameen, Nadia A. .

DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (11) :2826-2845

[8]

Randomised clinical trials: linaclotide phase 3 studies in IBS ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints.[J].E. M. M. Quigley;J. Tack;W. D. Chey;S. S. Rao;J. Fortea;M. Falques;C. Diaz;S. J. Shiff;M. G. Currie;J. M. Johnston.Aliment Pharmacol Ther.2012, 1

[9]

Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation [J].

Tack, Jan ;

Corsetti, Maura .

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (10) :1327-1335

[10]

Prucalopride: safety, efficacy and potential applications [J].

Quigley, Eamonn M. M. .

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (01) :23-30

← 1 2 →